Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?

@article{Pokorny2005DoesAD,
  title={Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?},
  author={Herwig Pokorny and Michael F. X. Gnant and Susanne Rasoul-Rockenschaub and Bernd Gollackner and Birgit Steiner and G{\"u}nter Steger and Rudolf Steininger and Ferdinand Muehlbacher},
  journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  year={2005},
  volume={5 4 Pt 1},
  pages={788-94}
}
The aim of this prospective randomized study was to determine whether additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma (HCCA) treated by liver transplantation. Stratification parameters were tumor stage (UICC I-IVa), gender, age 50 years, alpha-fetoprotein 20 ng/mL, cirrhosis and HbsAg status. For pre-operative… CONTINUE READING